Barrage Khalil 5
5 · Protagenic Therapeutics, Inc.\new · Filed Feb 24, 2020
Insider Transaction Report
Form 5
Barrage Khalil
Director
Transactions
- Purchase
Convertible Note
2019-11-05$50000.00/shExercise: $1.25From: 2019-11-05Exp: 2023-11-06→ Common stock, par value $0.0001 per share (40,000 underlying)
Footnotes (1)
- [F1]The reported transaction is the purchase of a convertible note, convertible at the holder's discretion at any time into common stock at the rate of $1.25 per share.